ConductScience.org, home

Trial · NCT00059228

Clinical Trial of Estrogen for Postpartum Depression

NCT00059228, Phase 2, Terminated, National Institute of Mental Health (NIMH); results first posted 2018-06-13

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Clinical Trial of Estrogen for Postpartum Depression. Trials, record NCT00059228. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00059228

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clinical Trial of Estrogen for Postpartum Depression
NCT number
NCT00059228
Status
Terminated
Phases
Phase 2
Enrollment
12 participants, actual
Lead sponsor
National Institute of Mental Health (NIMH)
Conditions
Postpartum Depression, Depression
Interventions
17beta Estradiol, Placebos
First posted
2003-04-22
Last updated
2018-06-13
Results first posted
2018-06-13

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBeck Depression Inventory6 weeks
The Beck Depression Inventory (BDI) is a 21-question multiple-choice self-report inventory for measuring the severity of depression. Higher total scores indicate more severe depressive symptoms. The range of scores vary from 0 to 63 (highest possible total) for the whole test. A score of 0 - 10 indicates minimal depression, while a score of over 40 indicates extreme depression. No subscales were used for this outcome.
PrimaryBeck Depression InventoryBaseline
The Beck Depression Inventory (BDI) is a 21-question multiple-choice self-report inventory for measuring the severity of depression. Higher total scores indicate more severe depressive symptoms. The range of scores vary from 0 to 63 (highest possible total) for the whole test. A score of 0 - 10 indicates minimal depression, while a score of over 40 indicates extreme depression. No subscales were used for this outcome.

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYBeck Depression Inventory6 weeksThe analysis included only those subjects who had taken Estradiol and PlaceboUnits on a scaleLEAST_SQUARES_MEAN
PRIMARYBeck Depression InventoryBaselineThe analysis included only those subjects who had taken Estradiol and Placebounits on a scaleMEAN

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Beck Depression InventoryEstradiol15.84Standard Error 3.91Units on a scale
Beck Depression InventoryPlacebo5.3Standard Error 3.19Units on a scale
Beck Depression InventoryEstradiol26Standard Error 2.62units on a scale
Beck Depression InventoryPlacebo27.67Standard Error 3.72units on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDEstradiol6
Overall StudySTARTEDPlacebo6
Overall StudyCOMPLETEDEstradiol6
Overall StudyCOMPLETEDPlacebo5
Overall StudyNOT COMPLETEDEstradiol0
Overall StudyNOT COMPLETEDPlacebo1

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherNauseaGastrointestinal disordersEstradiol06
otherNauseaGastrointestinal disordersPlacebo16

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityEstradiol06
Total, all-cause mortalityPlacebo06
Total, other adverse eventsEstradiol06
Total, other adverse eventsPlacebo16
Total, serious adverse eventsEstradiol06
Total, serious adverse eventsPlacebo06

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
8598756BACKGROUNDPubMed
10831472BACKGROUNDPubMed
11411813BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Estradiol vs Placebo: deaths from any causeTrial comparisons
Estradiol vs Placebo: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00059228

GET https://conductscience.org/api/trials/v1/NCT00059228/registered